ABBV vs PAVM

AbbVie Inc. (ABBV) is a well-established mega-cap pharmaceutical company with a robust product portfolio, strong financial health, and a leading position in key therapeutic areas. It excels as a stable dividend payer and a defensive holding. However, its fundamental characteristics, including its immense market capitalization ($397.29B), the mature nature of the pharmaceutical industry, high R&D c...

PAVmed Inc. (PAVM) remains a highly speculative, high-risk, high-reward investment, yet its financial runway has materially improved since the last analysis. The completion of a $30M Series D preferred stock and $15M senior secured note financing provides a crucial $45M capital infusion, significantly alleviating the immediate cash burn and precarious financial position that previously justified a...